Source: Virtual Congress 2020 – Thoracic oncology
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
I. Opitz (Zurich, Switzerland). Perioperative systemic therapy in resectable lung cancer: from standard operating procedures to immuno-oncology and back. Virtual Congress 2020 – Thoracic oncology

Member's Comments

No comment yet.

Related content which might interest you: Palliative care or standard chemotherapy in lung cancer patients? Source: Annual Congress 2012 - Ethics Grand Round: an interactive session Year: 2012 ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) Source: Eur Respir J 2009; 34: 17-41 Year: 2009 Multimodality lung cancer therapy – nonsurgical complications Source: Annual Congress 2008 - High-risk patients for major lung cancer surgery Year: 2008 ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) Source: Guideline 2009 Year: 2009 Combined and organ-saving operations in patients with advanced lung cancer after induction chemotherapy Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010 Preoperative endobronchial photodynamic therapy improves surgical radicalism for locally advanced NSCLC Source: Annual Congress 2012 - From the laser through the stent to the valve: the broad spectrum of interventional pneumology Year: 2012 Clinical outcomes of stereotactic ablative body radiotherapy (SABR) in medically inoperable early stage lung cancer patients Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021 Preoperative pulmonary complication risk assessment in patients undergoing curative surgery for lung cancer Source: International Congress 2017 – Thoracic surgery Year: 2017 Impact of neoadjuvant therapies on surgical indications and early postoperative outcome Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts Year: 2005 Checkpointinhibition in lung cancer – already standard of care in any line of therapy?  Source: International Congress 2017 – Lung cancer immunotherapy Year: 2017 Clinical profile of patients with lung cancer submitted to the pulmonary rehabilitation and conventional physiotherapy Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010 Does consolidation chemotherapy improves survival for locally advanced non-small-cell lung cancer patients receiving concurrent chemoradiotherapy? Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 Neoadjuvant chemotherapy for NSCLC, lung function and surgical therapy – which is their connection? Source: International Congress 2019 – Lung function testing: from experimental investigations to clinical applications Year: 2019 Early complications after lung resections at patients treated for lung cancer with and without neoadjuvant hemiotheraphy Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011 SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection Source: Eur Respir J, 56 (5) 2000118; 10.1183/13993003.00118-2020 Year: 2020 Is bronchoscopic photodynamic therapy a therapeutic option in lung cancer? Source: Eur Respir J 2003; 22: 535-541 Year: 2003 Early stage nonsmall-cell lung cancer: therapeutic options (surgery, adjuvant and neoadjuvant therapy) Source: Annual Congress 2011 - PG10 Management of thoracic tumours in practice: a HERMES basic course Year: 2011